Castro, J.I.; Araujo-Rodríguez, D.G.; Valencia-Llano, C.H.; López Tenorio, D.; Saavedra, M.; Zapata, P.A.; Grande-Tovar, C.D.
Biocompatibility Assessment of Polycaprolactone/Polylactic Acid/Zinc Oxide Nanoparticle Composites under In Vivo Conditions for Biomedical Applications. Pharmaceutics 2023, 15, 2196.
https://doi.org/10.3390/pharmaceutics15092196
AMA Style
Castro JI, Araujo-Rodríguez DG, Valencia-Llano CH, López Tenorio D, Saavedra M, Zapata PA, Grande-Tovar CD.
Biocompatibility Assessment of Polycaprolactone/Polylactic Acid/Zinc Oxide Nanoparticle Composites under In Vivo Conditions for Biomedical Applications. Pharmaceutics. 2023; 15(9):2196.
https://doi.org/10.3390/pharmaceutics15092196
Chicago/Turabian Style
Castro, Jorge Iván, Daniela G. Araujo-Rodríguez, Carlos Humberto Valencia-Llano, Diego López Tenorio, Marcela Saavedra, Paula A. Zapata, and Carlos David Grande-Tovar.
2023. "Biocompatibility Assessment of Polycaprolactone/Polylactic Acid/Zinc Oxide Nanoparticle Composites under In Vivo Conditions for Biomedical Applications" Pharmaceutics 15, no. 9: 2196.
https://doi.org/10.3390/pharmaceutics15092196
APA Style
Castro, J. I., Araujo-Rodríguez, D. G., Valencia-Llano, C. H., López Tenorio, D., Saavedra, M., Zapata, P. A., & Grande-Tovar, C. D.
(2023). Biocompatibility Assessment of Polycaprolactone/Polylactic Acid/Zinc Oxide Nanoparticle Composites under In Vivo Conditions for Biomedical Applications. Pharmaceutics, 15(9), 2196.
https://doi.org/10.3390/pharmaceutics15092196
